期刊文献+

2型糖尿病合并代谢综合征患者肝酶变化及相关性研究 被引量:6

The correlation of liver enzymes and metabolic syndrome in newly diagnosed type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨新诊断的2型糖尿病合并代谢综合征(MS)的患者血清肝酶水平的变化及与代谢综合征各组分的相关性。方法收集该院291例新诊断的2型糖尿病患者,并将其分为MS组、非MS(NMS)组,测量身高、体重、腰围和血压,并计算体重指数(BMI)和腰臀比;采血检测空腹血糖(FBG)、餐后2 h血糖(2h PBG)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、谷氨酰转移酶(GGT)、三酰甘油(TG)、胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)、空腹胰岛素(FINS)和餐后2 h胰岛素(2hINS),计算胰岛素抵抗指数(HOMA-IR),并对各指标进行比较分析。结果 MS组ALT、AST、GGT、腰围、BMI、TG、TC、LDL-C、收缩压(SBP)、舒张压(DBP)、HOMA-IR、2h PBG、FINS和2h INS均显著高于NMS组(P<0.05)。Pearson相关分析显示:ALT与BMI、DBP、HOMA-IR、FINS呈正相关(P<0.05);AST与BMI、SBP、DBP、FINS呈正相关(P<0.05);GGT与TG、HOMA-IR、FINS呈正相关(P<0.05)。以HOMA-IR为因变量进行多元逐步回归分析,进入回归方程的因素为BMI、TG和ALT,HOMA-IR与BMI、TG及ALT呈正相关。结论 2型糖尿病合并MS患者血清肝酶水平包括ALT、AST和GGT均明显增高,且以ALT与MS相关最为密切。 [ Objective ] To explore the relationship between liver enzymes and metabolic syndrome (MS) in newly diagnosed type 2 diabetes mellitus. [Methods] 291 patients with newly diagnosed type 2 diabetes were divided into MS group and NMS group. Body Mass Index (BMI), waist circumference, blood pressure were measured, liver en- zymes, plasma glucose, lipids and insulin were detected, insulin resistance index (HOMA-IR) was calculated accord- ing to the formula. The relationship of liver enzymes and MS in two groups were studied. [ Results ] The results of alanineaminotransferase (ALT), aspartateaminotransferase (AST),'y-glutamyltransferase (GGT), waist circumference, BMI, systolic blood pressure(SBP), diastolic blood pressure (DBP), total cholesterol (TC), serum triglyceride (TG), low density lipoprote in cholesterol (LDL-C), 2 h postprandial plasma glucose (2 h PBG), fasting and 2 h postprandial in- sulin (FINS and 2 h INS), HOMA-IR in MS group were significantly increased than that of NMS group (P 〈0.05). Pearson correlation analysis showed there were positively correlations between ALT and BMI, DBP, HOMA-IR, fast- ing insulin (P 〈0.05), between AST and BMI, SBP, DBP, fasting insulin (P 〈0.05), and between GGT and TG, HOMA-IR, fasting insulin (P 〈0.05). Multiple stepwise regression analysis showed there was a positive correlation between HOMA-IR and BMI, TG and ALT. [Conclusion] The expression of ALT, AST and GGT in newly diag-nosed type 2 diabetic patients with metabolic syndrome were significantly increased, and the ALT had a most closely associated with MS.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2014年第1期41-44,共4页 China Journal of Modern Medicine
关键词 2型糖尿病 代谢综合征 谷丙转氨酶 谷草转氨酶 谷氨酰转移酶 diabetes mellitus, type 2 metabolic syndrome alanineam inotransferase aspartate aminotransferase γ- glutamyltransferase
  • 相关文献

参考文献7

  • 1刘蒙,颜红梅,高鑫,高键.非酒精性脂肪肝病患者中肝酶与代谢综合征的关系[J].中华医学杂志,2007,87(4):253-255. 被引量:21
  • 2中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 3NANNIPIERI M, GONZALES C, BALDI S, et al. Liver enzymes,the metabolic syndrome and incident diabetes:the mexico city Di- abetes Study[J]. Diabetes Care, 2005, 28(7): 1757-1762.
  • 4廖云飞,陈璐璐,曾天舒,郑涓.代谢综合征患者血清丙氨酸转氨酶相关因素分析[J].中国糖尿病杂志,2008,16(3):147-149. 被引量:24
  • 5HICKMAN IJ, WHITEHEAD JP, PRINS JB, et al. Raised alanine transaminase and decreased adiponectin are features of the metabolic syndrome in patients with type 2 diabetes[J]. Diabetes Obes Metab, 2007, 9(3): 438-440.
  • 6FORLANI G, DI BONITO P, MANNUCCI E, et al. Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome [J]. J Endocrinol Invest, 2008, 31(2): 146-152.
  • 7MOFRAD P, CONTOS MJ, HAQUE M, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values[J]. Hepatology, 2003, 37(6): 1286-1292.

二级参考文献21

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 2范建高,朱军,李新建,戴菲,李锐,宋晓敏,陈兰,李锋,陆元善.上海市成人饮酒与代谢综合征关系的流行病学调查[J].肝脏,2005,10(1):11-15. 被引量:21
  • 3黄昌华,孙仕强,付孟清,刘伯宇,钟富玲.深圳市公务员BMI与高血压、高胆固醇、高血糖关系[J].中国热带医学,2005,5(6):1369-1370. 被引量:7
  • 4颜红梅,高鑫,刘蒙,顾迁,张斌,李湘,高键,赵耐青.非酒精性脂肪肝与代谢综合征关系的研究[J].中国糖尿病杂志,2006,14(5):326-328. 被引量:74
  • 5Marchesini G,Bugiansi E,Forlani G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome.Hepatology,2003,37:917-923.
  • 6Nannipieri M,Haffner SM,Ferrannini E,et al.Liver enzymes,the metabolic syndrome and incident diabetes:the mexico city Diabetes Study.Diabetes Care,2005,28:1757-1762.
  • 7Schindhelm RK,Diamant M,Bakker SJL,et al.Liver alanine aminotransferase,insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus.Eur J Clin Invest,2005,35:369-374.
  • 8Hanley AJ,Williams K,Haffner SM,et al.Elevations in markers of liver injury and risk of type 2 diabetes the insulin resistance atherosclerosis Study.Diabetes,2004,53:2623-2632.
  • 9Dixon JB,Bhathal PS,O' Brien PE.Nonalcoholic fatty liver disease:predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.Gastroenterology,2001,121:91-100.
  • 10Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).JAMA,2001,285:2486-2497.

共引文献3085

同被引文献48

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部